Brian Goff - Chief Executive Officer, Director at Agios Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
AGIO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Brian Goff - trading volume in the past year for Agios Pharmaceuticals, Inc.

Holdings reported by Brian Goff for Agios Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common stock 124K $4.53M $36.67 Aug 8, 2025 Direct
Performance share units 12.8K $3.4M $44.39 Jun 24, 2025 Direct Common stock
Restricted stock units 0 $1.28M $35.54 Aug 8, 2025 Direct Common stock
Stock options (right to buy) 143K Mar 1, 2025 Direct Common stock

Transactions reported by Brian Goff for Agios Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.